XENON XE-129, HYPERPOLARIZED
UNII 726Q6M95ZA

Substance Identification & Data

This profile provides standardized clinical and technical data for Xenon Xe-129, Hyperpolarized, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 726Q6M95ZA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 13965-99-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

726Q6M95ZA

CAS Registry Number

13965-99-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

XENON XE-129, HYPERPOLARIZED

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

726Q6M95ZA

The specific atomic composition represented as a molecular structure string.

InChIKey

Xe

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

FHNFHKCVQCLJFQ-YPZZEJLDSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C128034

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

10290811

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[129Xe]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Xenon Xe-129, Hyperpolarized. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.